172 words 3 4 Abstract 3 7 Zika virus (ZIKV) has re-emerged in the population and caused 3 8 unprecedented global outbreaks. Here, the transcriptomic consequences of 3 9
Introduction 6
Results 9 8 ZIKV targets human peripheral blood monocytes and macrophages. 9 9 CD14 + monocytes have been reported to be the main targets of ZIKV 1 0 0 during infection (6) (7) (8) (9) . In this study, human primary CD14 + monocytes were 1 0 1 first isolated from fresh peripheral blood mononuclear cells (PBMCs) to 1 0 2 enrich this cell type to >90% of the total cell population ( Figure 1A ). In host-virus interaction would have taken place (11). Data obtained showed 1 1 0 that ZIKV infection of MDMs was more significant than infection of 1 1 1 monocytes in all five donors (~40% compared to ~20% at 72 hpi, 1 1 2 respectively) ( Figure 1C ). A decrease in viral load was observed in the 1 1 3
virus-infected MDMs between the two time points, whereas the viral load 1 1 4 remained consistent in infected monocytes over time ( Figure 1D ). human volunteers also showed that CD14 + monocytes were the main 1 1 7 immune subsets infected (Supplemental Figure 1 ). Genome variation in ZIKV during infection of the peripheral blood. In genomes that had additional nucleotide differences at six different positions 1 4 3 (Table 1) . These nucleotide differences (Table 1) were visualized as a 1 4 4 maximum likelihood phylogenetic tree, where the input stock was used as the 1 4 5 reference sample ( Figure 2B ). There were only eight high frequency transition 1 4 6 mutations to choose from (log 10 8 = 0.9, see Figure 2A ), increasing the ZIKV-infected non-depleted PBMCs led to slightly more cell death Figure 10B ). marked differences between these cell types (26, 27) . In this study, human 2 9 3 primary monocytes were naturally differentiated into MDMs without any bias 2 9 4
NK cells (Supplemental
for an M1 or M2 macrophage phenotype (28) . Given that these cells are responses during infection will open avenues to exploit their function for 2 9 7 therapeutic benefits. The level of ZIKV infection (as assessed by the amount of ZIKV antigen and genome copy number) was higher in MDMs than monocytes, CXCL9, CXCL10, CXCL11 and CCL5 (identified as the top genes in 3 5 0 the pathway) are known chemokines to stimulate NK-cell activation (37, 38) .
The increased transcript abundance of these immune mediators, coupled levels of CD69, which is a phenomenon also reported for the flavivirus tick- mice, which lack NK cells (51), as a model of ZIKV infection also suggested 3 8 5 18 a protective role for these immune cell given that these animals succumbed 3 8 6
to cortical malformations (52). Likewise, NK-cell-mediated immune 3 8 7
response was significantly increased in healthy volunteers receiving a 3 8 8 vaccination for the closely related yellow fever virus (53). Interestingly, multiplex quantification of secreted immune mediators and IFNγ, two NK-cell related cytokines, were below detection limit. However, freshly isolated PBMCs stimulated with culture supernatants from 3 9 3
ZIKV-infected PBMCs resulted in increased priming of NK cells, clearly 3 9 4
indicating that the concoction of immune mediators are capable in driving 3 9 5
NK-cell activation. Nonetheless, the, depletion of CD14 + monocytes would abrogate this have been reported to be high in ZIKV patients (20) virus was propagated as previously described (8) were prepared from fresh human PBMCs as previously described (8) The viral load was quantified from 140 µl of the infected cell suspension.
8 9
Negative controls were cells undergoing the same infection conditions in the 4 9 0 absence of infectious ZIKV particles. These controls are referred to as mock-4 9 1 infected samples. PBMCs stimulation assay. Fresh PBMCs were isolated as described above (Sigma-Aldrich). Cells were subsequently treated with 1X Brefeldin Biosciences). RNA was quantified on a Nanodrop 1000 spectrophotometer (Thermo Fisher 5 1 1 Scientific). staining was then performed with a flavivirus-specific mouse monoclonal antibody (clone 4G2) (Millipore) followed by secondary staining with a goat 5 1 9
anti-mouse IgG F(ab') 2 antibody (Invitrogen). Cells were then specifically CD94, CD16, CD69, CD107a, NKG2D and NKG2A. The stained cells were 5 2 7
subsequently incubated with FACS lysing solution (BD Biosciences) to lyse 5 2 8
the red blood cells. CD56+ cells were first identified and were subsequently 5 2 9
further defined with the CD94 surface marker to give three other subsets - analysis. Stained PBMCS were fixed and permeabilized as described above 5 3 6 before intracellular staining of ZIKV antigen and IFNγ.
3 7
All antibodies used were mouse anti-human and were obtained from infected PBMCs were measured simultaneously using the ProcartaPlex TM Ebola virus associated with increasing pathogenicity. Genome Biol. factor activates nuclear factor-kappaB and induces monocyte necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist. Immunology. 1991;73(4):450-6. as sources and targets of the IL-10 family members? J Immunol. Figure 5 : Activation of CD56 + cells in patients infected with ZIKV. (A) Gating strategy of CD56 + cell subsets and their expression of CD16 and CD69. CD56 + cells were first gated from CD45 + lymphocytes from peripheral blood mononuclear cells isolated from patients. These populations were further gated into three populations based on the expression of surface marker CD94: CD94hiCD56bright cells (blue), CD94hiCD56dim (green) and CD94loCD56dim (red). The data presented correspond to a representative patient infected with ZIKV. Cells from a healthy control are overlaid and depicted as the black population (Q8). (B) Compiled data on the percentage of gated subsets that are positive for CD16 (Q5 and Q6) and CD69 (Q6 and Q7). Patients (n=9) are depicted as filled circles, and healthy controls (n=5) are depicted as clear circles. All data are presented as mean ± SD. *P < 0.05, by Mann Whitney U test, two tailed. Abbreviations: NK, natural killer; ZIKV, Zika virus. Data shown were derived from seven donors. Lineage markers CD3, CD19, CD20 and CD14 have been included to rule out the presence of non-NK cells. All data are presented as mean ± SD. *P < 0.05, **P < 0.01, by Mann Whitney U test, two tailed. Viral load data was not statistically significant between the two conditions by Mann Whitney U test, two tailed. Abbreviations; NK, natural killer; PMBC, peripheral blood mononuclear cell; hpi, hours post-infection. The phylogenetic tree shown in Figure 3B revealed specific nucleotide differences at 6 different positions within the consensus sequence. All samples included had a mean coverage of greater than 10. PF/ZIKV/HPF/2013 represents the virus used for the infection and therefore, denoted as the reference sample in this analysis. Abbreviations: MNC, monocytes; MDM, monocyte-derived macrophage. A Note that minor variant file numbering of positions starts at 0 rather than 1. 0.00108 0.00543 0.00108 0.99239 0 Table showing the frequency distribution of minor nucleotide variants at six positions in the consensus sequence. Major variant (i.e. the consensus nucleotide) at each position is indicated by the nucleotide with the highest frequency. A Note that minor variant file numbering of positions starts at 0 rather than 1.
